Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Girl with very rare health condition just 'wants to be like everybody else'
Matilda was diagnosed with a very rare syndrome but her parents 'want her to be able to go out in the world and do what she ...
The Manila Times5h
Trethera Treats a Late Stage, Heavily Pretreated Amyotrophic Lateral Sclerosis (ALS) Patient with TRE 515
Trethera Corporation ("Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune ...
Rare condition leaves girl 'trapped in her body' and suffering 40 falls a day
Matilda Monerawela, 10, from Torbay, Devon, is one of just 430 individuals worldwide diagnosed with CTNNB1 syndrome ...
TMCnet6h
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas
NeOnc Technologies Holdings, Inc. (NASDAQ Global Market: NTHI), a clinical-stage medical biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare ...
ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the fourth quarter and full-year ended December 31, 2024, and ...
$4.9m drug trial targets hidden dangers of heart surgery to brain, kidney function
The institute is now working to eliminate such risks with a $4.9m multidisciplinary drug trial. The drug is used to cool ...
The Manila Times8h
Harbour BioMed Reports Full Year 2024 Financial Results
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed ('HBM' or the 'Company'; ...
TMCnet13h
BioVersys Announces Important BV100 Patent Granted by Chinese Patent Office
BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...
Is long-acting HIV treatment as good as taking daily pills?
If all is good, then why do we need new options? Yes, HIV treatment – daily oral regimen – is lifesaving and good – access to ...
Cuts to science research funding cut American lives short—federal support is essential for medical breakthroughs
Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from ...
A church that said it fought to clean up Drake neighborhood is now part of its problems
A pastor told the story of how the congregation drove drug dealers from Des Moines' Drake neighborhood. But it replaced them ...